{"id":1069257,"title":"DSEN Abstract: Exposure to valsartan products with nitrosamine impurities in the US, Canada, and Denmark - CIHR","sourceCode":"cihr","sourceName":"Canadian Institutes of Health Research","language":"en","captureDate":"2026-04-17","captureTimestamp":"2026-04-17T02:30:47.480000+00:00","jobId":8,"originalUrl":"https://cihr-irsc.gc.ca/e/53927.html","snippet":"DSEN Abstract Exposure to valsartan products with nitrosamine impurities in the US, Canada, and Denmark A study conducted by the Canadian Network for Observational Drug Effect Studies (CNODES) Our findings suggest that many patients received valsartan products with nitrosamine…","rawSnapshotUrl":"/api/snapshots/raw/1069257","browseUrl":"https://replay.healtharchive.ca/job-8/20260417023047/https://cihr-irsc.gc.ca/e/53927.html#ha_snapshot=1069257","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}